GlassScriptPhysician profile
Karin K Hipp
NPI 1679544886
$3,860.81
in general payments reported to CMS, 2019-2025
21 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $591 · 2022: $1,034 · 2023: $1,031 · 2024: $826 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,059 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,058.54 |
| Education | $177.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,507.07 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $519.37 | 2021-2025 | Dupixent |
| Janssen Biotech, INC. | $362.19 | 2022-2024 | Tremfya |
| Novartis Pharmaceuticals Corporation | $259.53 | 2021-2025 | |
| Galderma Laboratories, L.P. | $241.98 | 2021-2023 | |
| Almirall LLC | $167.08 | 2022-2023 | Klisyri |
| Amgen INC. | $124.46 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $117.72 | 2022-2024 | Sotyktu |
| Lilly USA, LLC | $80.89 | 2021-2023 | Taltz, Olumiant |
| Leo Pharma INC. | $74.02 | 2021-2024 | Adbry |
| Allergan, INC. | $68.09 | 2021-2022 | |
| Ucb, INC. | $56.83 | 2021-2024 | Bimzelx |
| Incyte Corporation | $51.79 | 2022-2025 | Opzelura |
| Genzyme Corporation | $46.86 | 2022-2024 | |
| Merz North America, INC. | $43.36 | 2021-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $38.96 | 2022-2023 | Absorica Ld, Winlevi |
| Journey Medical Corporation | $31.17 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.22 | 2022 | |
| Dermavant Sciences, INC. | $19.12 | 2023 | Vtama |
| Biofrontera INC. | $18.12 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Pfizer INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karin Hipp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.